The role of Shp2 (PTPN11) in cancer
- 1 February 2007
- journal article
- review article
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 17 (1) , 23-30
- https://doi.org/10.1016/j.gde.2006.12.011
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2The EMBO Journal, 2006
- Leukemia-Associated, Constitutively Active Mutants of SHP2 Protein Tyrosine Phosphatase Inhibit NF1 Transcriptional Activation by the Interferon Consensus Sequence Binding ProteinMolecular and Cellular Biology, 2006
- Protein-tyrosine phosphatases and cancerNature Reviews Cancer, 2006
- Germline KRAS mutations cause Noonan syndromeNature Genetics, 2006
- Diversity and Functional Consequences of Germline and Somatic PTPN11 Mutations in Human DiseaseAmerican Journal of Human Genetics, 2006
- Diverse Biochemical Properties of Shp2 MutantsJournal of Biological Chemistry, 2005
- Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemiaJournal of Human Genetics, 2005
- Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemiaBlood, 2004
- Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorderBlood, 2004
- Protein Tyrosine Phosphatases in the Human GenomeCell, 2004